AKR1B10P1 and hepatocellular carcinoma: By re‐introducing SOX4 in the HCC cells treated with AKR1B10P1 depletion for a rescue experiment purpose, we observed a remarkably reverse change in the phenotypes induced by AKR1B10P1 modulation.